Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Jamison

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
The Oncologist|March 18, 2026
Phase 2 Study of Azacitidine plus Pembrolizumab as Second-Line Treatment in Patients with Locally Advanced or Metastatic Pancreatic Ductal AdenocarcinomaRachael A Safyan, Ruth A White, Tamas A Gonda, et al.
American Journal of Human Genetics|January 13, 2000
Full-genome scan for linkage in 50 families segregating the bipolar affective disease phenotypeC Friddle, R Koskela, K Ranade, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
The Oncologist|March 18, 2026
Phase 2 Study of Azacitidine plus Pembrolizumab as Second-Line Treatment in Patients with Locally Advanced or Metastatic Pancreatic Ductal AdenocarcinomaRachael A Safyan, Ruth A White, Tamas A Gonda, et al.
American Journal of Human Genetics|January 13, 2000
Full-genome scan for linkage in 50 families segregating the bipolar affective disease phenotypeC Friddle, R Koskela, K Ranade, et al.
Pageof 4